Dermot Murnaghan Joins Prostate Cancer Research As An Ambassador

PRESS RELEASE 29/06/25

 

Former News Presenter Dermot Murnaghan has joined Prostate Cancer Research as an ambassador. In this role he will help drive forward the charity’s campaign for a national screening programme for men at higher risk of prostate cancer.

 

The announcement follows Murnaghan’s recent disclosure that he is living with stage four prostate cancer, bringing personal significance to his new role and highlighting the pressing need for screening reform.

 

As a Prostate Cancer Research ambassador, Murnaghan will be supporting the charity’s mission of advancing groundbreaking research and treatments to create a future where prostate cancer no longer impacts lives.

 

This backing from the former ITV, BBC, and Sky News journalist comes at a crucial time for Prostate Cancer Research, as its Proactive For Your Prostate campaign continues to gain momentum. The campaign is calling for the immediate introduction of a targeted national screening programme for men at high risk, alongside increased investment in improved diagnostic tools to pave the way for a universal screening programme in the future.

 

Prostate cancer is now the most commonly diagnosed cancer among men in the UK. Early detection is crucial, as a late-stage diagnosis significantly limits treatment options and can greatly diminish quality of life.

Dermot Murnaghan said:


“My recent diagnosis with stage four advanced prostate cancer has made the fight against this disease intensely personal. While I am fortunate to be receiving excellent care and responding well to treatment, my situation has given me a new and urgent sense of purpose.

“I am now a proud Ambassador for the charity Prostate Cancer Research, and I’m honoured to support an organisation that is funding innovative research that will lead to better diagnostics and treatments, and campaigning for life-saving and urgently needed screening reform.

“The current ‘informed choice’ prostate cancer testing system is simply not good enough – it’s failing men and their families. I’ve seen firsthand how this disease can advance without obvious symptoms.

“That is why I am putting my full support behind Prostate Cancer Research’s ‘Proactive for Your Prostate’ campaign. It is a direct and necessary call to action. We need a targeted screening programme for high-risk men immediately, and we must invest in better diagnostic tools, including AI, to create a universal screening programme for all men as soon as possible. Let’s campaign together for the policy changes that will save lives.”

 

Oliver Kemp, CEO of Prostate Cancer Research, said:


“We are honoured to welcome Dermot Murnaghan as an ambassador for Prostate Cancer Research. His commitment to our mission of transforming the landscape of prostate cancer diagnosis, treatment and care is truly valued. With urgent need for nationwide screening, Dermot’s support will be instrumental in raising awareness and saving lives.”

 

ENDS

Contact:


Prostate Cancer Research: Kath Coleman [email protected]; Jess Farmery
[email protected]

 

About Prostate Cancer Research


Prostate Cancer Research is a patient-centric research and information provision charity dedicated to improving and saving the lives of people with prostate cancer.

As well as working towards greater equity, access to and parity of care, they fund innovative research projects at world-leading institutions that are working towards breakthroughs in the prevention, diagnosis and treatment of prostate cancer. This includes research into tackling health inequities, improving current treatments and developing novel drug targets.

The charity also supports translational research to ensure any breakthroughs have a greater chance of reaching the patients who need them. Over the past two years, they have more than trebled their research, established the infopool, an educational website to support and empower patients and launched Prostate Progress, the UK’s first patient-centric data platform powered by NHS data.

For more information, please visit: www.pcr.org.uk

 

Press enter or esc to cancel